– Reuters Citing Sources
Piper Sandler Initiates Coverage On Axsome Therapeutics with Neutral Rating, Announces Price Target of $75
Piper Sandler analyst David Amsellem initiates coverage on Axsome Therapeutics (NASDAQ:AXSM) with a Neutral rating and announces Price Target of $75.